Clarkston Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6M | Buy |
33,477
+32,802
| +4,860% | +$13.3M | 0.29% | 56 |
|
|
2025
Q1 | $336K | Hold |
675
| – | – | 0.01% | 131 |
|
|
2024
Q4 | $351K | Hold |
675
| – | – | 0.01% | 133 |
|
|
2024
Q3 | $418K | Sell |
675
-41
| -6% | -$25.4K | 0.01% | 124 |
|
|
2024
Q2 | $396K | Hold |
716
| – | – | 0.01% | 128 |
|
|
2024
Q1 | $416K | Sell |
716
-50
| -7% | -$29.1K | 0.01% | 127 |
|
|
2023
Q4 | $407K | Hold |
766
| – | – | 0.01% | 122 |
|
|
2023
Q3 | $388K | Buy |
766
+50
| +7% | +$25.3K | 0.01% | 122 |
|
|
2023
Q2 | $374K | Hold |
716
| – | – | 0.01% | 125 |
|
|
2023
Q1 | $413K | Hold |
716
| – | – | 0.01% | 122 |
|
|
2022
Q4 | $394K | Sell |
716
-21
| -3% | -$11.6K | 0.01% | 133 |
|
|
2022
Q3 | $374K | Sell |
737
-21
| -3% | -$10.7K | 0.01% | 134 |
|
|
2022
Q2 | $412K | Buy |
758
+16
| +2% | +$8.7K | 0.01% | 134 |
|
|
2022
Q1 | $438K | Sell |
742
-129
| -15% | -$76.1K | 0.01% | 138 |
|
|
2021
Q4 | $581K | Buy |
871
+5
| +0.6% | +$3.34K | 0.01% | 114 |
|
|
2021
Q3 | $495K | Hold |
866
| – | – | 0.01% | 105 |
|
|
2021
Q2 | $437K | Hold |
866
| – | – | 0.01% | 109 |
|
|
2021
Q1 | $395K | Buy |
866
+267
| +45% | +$122K | 0.01% | 113 |
|
|
2020
Q4 | $279K | Buy |
599
+87
| +17% | +$40.5K | 0.01% | 103 |
|
|
2020
Q3 | $226K | Buy |
+512
| New | +$226K | 0.01% | 101 |
|